Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-127221
Filing Date
2023-04-28
Accepted
2023-04-28 16:32:52
Documents
10
Period of Report
2023-06-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A d499278ddef14a.htm DEF 14A 332812
2 GRAPHIC g499278dsp001.jpg GRAPHIC 2267
3 GRAPHIC g499278dsp001a.jpg GRAPHIC 1006
4 GRAPHIC g499278dsp001b.jpg GRAPHIC 906
5 GRAPHIC g499278dsp001c.jpg GRAPHIC 1230
6 GRAPHIC g499278dsp001d.jpg GRAPHIC 1222
7 GRAPHIC g499278dsp002.jpg GRAPHIC 964
8 GRAPHIC g499278dsp002a.jpg GRAPHIC 1080
9 GRAPHIC g499278dsp002b.jpg GRAPHIC 784
10 GRAPHIC g499278g01a03.jpg GRAPHIC 32739
  Complete submission text file 0001193125-23-127221.txt   393297
Mailing Address 75 STATE ST. SUITE 100 BOSTON MA 02109
Business Address 75 STATE ST. SUITE 100 BOSTON MA 02109 (617) 213-5054
HilleVax, Inc. (Filer) CIK: 0001888012 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41365 | Film No.: 23867136
SIC: 2836 Biological Products, (No Diagnostic Substances)